Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2019 / N 1

Современный алгоритм диагностики и лечения кардиоваскулярных и метаболических нарушений у пациентов с обструктивным апноэ сна
М.В. Горбунова, С.Л. Бабак, А.Г. Малявин

Список литературы

1. Бойцов С.А., Погосова Н.В., Бубнова М.Г., Драпкина О.М., Гаврилова Н.Е., Еганян Р.А., Калинина А.М., Карамнова Н.С., Кобалава Ж.Д., Концевая А.В., Кухарчук В.В., Лукьянов М.М., Масленникова Г.Я., Марцевич С.Ю., Метельская В.А., Мешков А.Н., Оганов Р.Г., Попович М.В., Соколова О.Ю., Сухарева О.Ю. Ткачева О.Н., Шальнова С.А., Шестакова М.В., Юферева Ю.М., Явелов И.С. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал 2018;23(6):7-122.
2. Obstructive sleep apnea syndrome (780.53-0). In: American Academy of Sleep Medicine. The International classification of sleep disorders. Darien, IL: American Academy of Sleep Medicine; 2010: 52-8.
3. Farney RJ, Walker BS, Farney RM, Snow GL, Walker JM. The STOP-Bang equivalent model and prediction of severity of obstructive sleep apnea: relation to polysomnographic measurements of the apnea/hypopnea index. Journal of Clinical Sleep Medicine 2011 Oct;7(5):459-65B.
4. Lombardi C, Tobaldini E, Montano N, Losurdo A, Parati G. Obstructive sleep apnea syndrome (OSAS) and cardiovascular system. La Medicina del Lavoro 2017 Aug;108(4):276-82.
5. Floras JS. Hypertension and sleep apnea. Canadian Journal of Cardiology 2015 Jul;31(7):889-97.
6. Khan A, Patel NK, O’Hearn DJ, Khan S. Resistant hypertension and obstructive sleep apnea. International Journal of Hypertension 2013 Apr;2013:193010.
7. Lombardi C, Pengo MF, Parati G. Systemic hypertension in obstructive sleep apnea. Journal of Thoracic Disease 2018 Dec;10(Suppl 34):S4231-43.
8. Walia HK, Li H, Rueschman M, Bhatt DL, Patel SR, Quan SF, Gottlieb DJ, Punjabi NM, Redline S, Mehra R. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. Journal of Clinical Sleep Medicine 2014 Aug;10(8):835-43.
9. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011 Nov;58(5):811-7.
10. Jin ZN, Wei YX. Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system. Journal of Geriatric Cardiology 2016 May;13(4):333-43.
11. Light M, McCowen K, Malhotra A, Mesarwi OA. Sleep apnea, metabolic disease, and the cutting edge of therapy. Metabolism 2018 Jul;84:94-8.
12. Booth A, Magnuson A, Fouts J, Foster MT. Adipose tissue: an endocrine organ playing a role in metabolic regulation. Hormone Molecular Biology and Clinical Investigation 2016 Apr;26(1):25-42.
13. Żelechowska P, Wiktorska M, Różalska S, Stasikowska-Kanicka O, Wągrowska-Danilewicz M, Agier J, Brzezińska-Błaszczyk E. Leptin receptor is expressed by tissue mast cells. Immunologic Research 2018 Oct;66(5):557-66.
14. Jaganathan R, Ravindran R, Dhanasekaran S. Emerging role of adipocytokines in type 2 diabetes as mediators of insulin resistance and cardiovascular disease. Canadian Journal of Diabetes 2018 Aug;42(4):446-56.e1.
15. Shechter A. Obstructive sleep apnea and energy balance regulation: a systematic review. Sleep Medicine Reviews 2017 Aug;34:59-69.
16. Yamagishi SI, Matsui T. Pigment epithelium-derived factor: a novel therapeutic target for cardiometabolic diseases and related complications. Current Medicinal Chemistry 2018;25(13):1480-500.
17. Bozic J, Borovac JA, Galic T, Kurir TT, Supe-Domic D, Dogas Z. Adropin and inflammation biomarker levels in male patients with obstructive sleep apnea: a link with glucose metabolism and sleep parameters. Journal of Clinical Sleep Medicine 2018 Jul;14(7):1109-18.
18. Ryan S. Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction. The Journal of Physiology 2017 Apr;595(8):2423-30.
19. Jehan S, Myers AK, Zizi F, Pandi-Perumal SR, Jean-Louis G, McFarlane SI. Obesity, obstructive sleep apnea and type 2 diabetes mellitus: epidemiology and pathophysiologic insights. Sleep Medicine and Disorders 2018;2(3):52-8.
20. Johnson KG, Johnson DC, Thomas RJ, Feldmann E, Lindenauer PK, Visintainer P, Kryger MH. Flow limitation/obstruction with recovery breath (FLOW) event for improved scoring of mild obstructive sleep apnea without electroencephalography. Sleep Medicine 2018 Nov 30. pii: S1389-9457(18)30582-3.
21. Chung F, Abdullah HR, Liao P. STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest 2016 Mar;149(3):631-8.
22. Малявин А.Г., Бабак С.Л., Адашева Т.В., Горбунова М.В., Мартынов А.И. Диагностика и ведение пациентов с резистентной артериальной гипертензией и обструктивным апноэ сна. Клинические рекомендации. Терапия 2018;1(19):4-42.
23. Wolf J, Narkiewicz K. Optimizing the management of uncontrolled/resistant hypertension. The importance of sleep apnoea syndrome. Current Vascular Pharmacology 2017;16(1):44-53.
24. Hilbert J, Yaggi HK. Patient-centered care in obstructive sleep apnea: a vision for the future. Sleep Medicine Reviews 2018 Feb;37:138-47.
25. Elfimova EM, Litvin AY, Chazova IE. The effectiveness of combination antihypertensive therapy in patients with arterial hypertension and additional risk factors: obesity and obstructive sleep apnea syndrome. Terapevticheskii Arkhiv 2018 Dec;90(12):28-33.
26. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by con-tinuous positive airway pressure applied through the nares. The Lancet 1981 Apr;1(8225):862-5.
27. Varounis C, Katsi V, Kallikazaros IE, Tousoulis D, Stefanadis C, Parissis J, Lekakis J, Siristatidis C, Manolis AJ, Makris T. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: a systematic review and meta-analysis. International Journal of Cardiology 2014 Jul;175(1):195-8.
28. Lin MT, Lin HH, Lee PL, Weng PH, Lee CC, Lai TC, Liu W, Chen CL. Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis. Sleep and Breathing 2015 Sep;19(3):809-17.
29. Martínez-García MA, Capote F, Campos-Rodríguez F, Lloberes P, Díaz de Atauri MJ, Somoza M, Masa JF, González M, Sacristán L, Barbé F, Durán-Cantolla J, Aizpuru F, Mañas E, Barreiro B, Mosteiro M, Cebrián JJ, de la Peña M, García-Río F, Maimó A, Zapater J, Hernández C, Grau SanMarti N, Montserrat JM; Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 2013 Dec;310(22):2407-15.
30. Sapiña E, Torres G, Barbé F, Sánchez-de-la-Torre M. The use of precision medicine to manage obstructive sleep apnea treatment in patients with resistant hypertension: current evidence and future directions. Current Hypertension Report 2018 Jun 8;20(7):60.
31. Joyeux-Faure M, Baguet JP, Barone-Rochette G, Faure P, Sosner P, Mounier-Vehier C, Lévy P, Tamisier R, Pépin JL. Continuous positive airway pressure reduces night-time blood pressure and heart rate in patients with obstructive sleep apnea and resistant hypertension: the RHOOSAS randomized controlled trial. Frontiers in Neurology 2018 May;9:318.

References

1. Boytsov SA, Pogosova NV, Bubnova MG, Drapkina OM, Gavrilova NE, Yeganyan RA, Kalinina AM, Karamnova NS, Kobalava ZhD, Kontsevaya AV, Kukharchuk VV, Lukyanov MM, Maslennikova GYa, Martsevich SYu, Metelskaya VA, Meshkov AN, Oganov RG, Popovich MV, Sokolova OYu, Sukhareva OYu, Tkacheva ON, Shalnova SA, Shestakova MV, Yufereva YuM, Yavelov IS. Cardiovascular prevention 2017. Russian national recommenda-tions. Russian Journal of Cardiology 2018;23(6):7-122 (In Russian).
2. Obstructive sleep apnea syndrome (780.53-0). In: American Academy of Sleep Medicine. The International classification of sleep disorders. Darien, IL: American Academy of Sleep Medicine; 2010: 52-8.
3. Farney RJ, Walker BS, Farney RM, Snow GL, Walker JM. The STOP-Bang equivalent model and prediction of severity of obstructive sleep apnea: relation to polysomnographic measurements of the apnea/hypopnea index. Journal of Clinical Sleep Medicine 2011 Oct;7(5):459-65B.
4. Lombardi C, Tobaldini E, Montano N, Losurdo A, Parati G. Obstructive sleep apnea syndrome (OSAS) and cardiovascular system. La Medicina del Lavoro 2017 Aug;108(4):276-82.
5. Floras JS. Hypertension and sleep apnea. Canadian Journal of Cardiology 2015 Jul;31(7):889-97.
6. Khan A, Patel NK, O’Hearn DJ, Khan S. Resistant hypertension and obstructive sleep apnea. International Journal of Hypertension 2013 Apr;2013:193010.
7. Lombardi C, Pengo MF, Parati G. Systemic hypertension in obstructive sleep apnea. Journal of Thoracic Disease 2018 Dec;10(Suppl 34):S4231-43.
8. Walia HK, Li H, Rueschman M, Bhatt DL, Patel SR, Quan SF, Gottlieb DJ, Punjabi NM, Redline S, Mehra R. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. Journal of Clinical Sleep Medicine 2014 Aug;10(8):835-43.
9. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 2011 Nov;58(5):811-7.
10. Jin ZN, Wei YX. Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system. Journal of Geriatric Cardiology 2016 May;13(4):333-43.
11. Light M, McCowen K, Malhotra A, Mesarwi OA. Sleep apnea, metabolic disease, and the cutting edge of therapy. Metabolism 2018 Jul;84:94-8.
12. Booth A, Magnuson A, Fouts J, Foster MT. Adipose tissue: an endocrine organ playing a role in metabolic regulation. Hormone Molecular Biology and Clinical Investigation 2016 Apr;26(1):25-42.
13. Żelechowska P, Wiktorska M, Różalska S, Stasikowska-Kanicka O, Wągrowska-Danilewicz M, Agier J, Brzezińska-Błaszczyk E. Leptin receptor is expressed by tissue mast cells. Immunologic Research 2018 Oct;66(5):557-66.
14. Jaganathan R, Ravindran R, Dhanasekaran S. Emerging role of adipocytokines in type 2 diabetes as mediators of insulin resistance and cardiovascular disease. Canadian Journal of Diabetes 2018 Aug;42(4):446-56.e1.
15. Shechter A. Obstructive sleep apnea and energy balance regulation: a systematic review. Sleep Medicine Reviews 2017 Aug;34:59-69.
16. Yamagishi SI, Matsui T. Pigment epithelium-derived factor: a novel therapeutic target for cardiometabolic diseases and related complications. Current Medicinal Chemistry 2018;25(13):1480-500.
17. Bozic J, Borovac JA, Galic T, Kurir TT, Supe-Domic D, Dogas Z. Adropin and inflammation biomarker levels in male patients with obstructive sleep apnea: a link with glucose metabolism and sleep parameters. Journal of Clinical Sleep Medicine 2018 Jul;14(7):1109-18.
18. Ryan S. Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction. The Journal of Physiology 2017 Apr;595(8):2423-30.
19. Jehan S, Myers AK, Zizi F, Pandi-Perumal SR, Jean-Louis G, McFarlane SI. Obesity, obstructive sleep apnea and type 2 diabetes mellitus: epidemiology and pathophysiologic insights. Sleep Medicine and Disorders 2018;2(3):52-8.
20. Johnson KG, Johnson DC, Thomas RJ, Feldmann E, Lindenauer PK, Visintainer P, Kryger MH. Flow limitation/obstruction with recovery breath (FLOW) event for improved scoring of mild obstructive sleep apnea without electroencephalography. Sleep Medicine 2018 Nov 30. pii: S1389-9457(18)30582-3.
21. Chung F, Abdullah HR, Liao P. STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest 2016 Mar;149(3):631-8.
22. Malyavin AG, Babak LS, Adasheva TV, Gorbunova MV, Martynov AI. Diagnosis and management of patients with resistant hypertension and obstructive sleep apnea. Clinical guidelines. Therapy 2018;1(19):4-42 (In Russian).
23. Wolf J, Narkiewicz K. Optimizing the management of uncontrolled/resistant hypertension. The importance of sleep apnoea syndrome. Current Vascular Pharmacology 2017;16(1):44-53.
24. Hilbert J, Yaggi HK. Patient-centered care in obstructive sleep apnea: a vision for the future. Sleep Medicine Reviews 2018 Feb;37:138-47.
25. Elfimova EM, Litvin AY, Chazova IE. The effectiveness of combination antihypertensive therapy in patients with arterial hypertension and additional risk factors: obesity and obstructive sleep apnea syndrome. Terapevticheskii Arkhiv 2018 Dec;90(12):28-33.
26. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by con-tinuous positive airway pressure applied through the nares. The Lancet 1981 Apr;1 (8225):862-5.
27. Varounis C, Katsi V, Kallikazaros IE, Tousoulis D, Stefanadis C, Parissis J, Lekakis J, Siristatidis C, Manolis AJ, Makris T. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: a systematic review and meta-analysis. International Journal of Cardiology 2014 Jul;175(1):195-8.
28. Lin MT, Lin HH, Lee PL, Weng PH, Lee CC, Lai TC, Liu W, Chen CL. Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis. Sleep and Breathing 2015 Sep;19(3):809-17.
29. Martínez-García MA, Capote F, Campos-Rodríguez F, Lloberes P, Díaz de Atauri MJ, Somo-za M, Masa JF, González M, Sacristán L, Barbé F, Durán-Cantolla J, Aizpuru F, Mañas E, Barreiro B, Mosteiro M, Cebrián JJ, de la Peña M, García-Río F, Maimó A, Zapater J, Her-nández C, Grau SanMarti N, Montserrat JM; Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA 2013 Dec;310(22):2407-15.
30. Sapiña E, Torres G, Barbé F, Sánchez-de-la-Torre M. The use of precision medicine to manage obstructive sleep apnea treatment in patients with resistant hypertension: current evidence and future directions. Current Hypertension Report 2018 Jun 8;20(7):60.
31. Joyeux-Faure M, Baguet JP, Barone-Rochette G, Faure P, Sosner P, Mounier-Vehier C, Lévy P, Tamisier R, Pépin JL. Continuous positive airway pressure reduces night-time blood pressure and heart rate in patients with obstructive sleep apnea and resistant hypertension: the RHOOSAS randomized controlled trial. Frontiers in Neurology 2018 May;9:318.
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]